Business
Pharma frenzy
Competition will make weight-loss drugs better, cheaper and bigger
Novo Nordisk and Eli Lilly face a growing number of challengers
Dig out your trousers
Are bosses right to insist that workers return to the office?
Company mandates are infuriating employees
Earned out?
America’s growing profits are under threat
Look beyond a bullish earnings season and risks loom
Mine your own business
BHP and Rio Tinto are heading in different directions
The strategies of the world’s two most valuable miners are diverging
Schumpeter
What if carmaking went the way of consumer electronics?
The Foxconnification of electric vehicles
Little frog, bigger pond
Poland’s stockmarket has a hot new entrant
The IPO of Zabka could help revive Warsaw’s beleaguered bourse
On the rack
Pity the superstar fashion designer
Creative directors are coming and going faster than the latest trends
Called out
Can artificial intelligence rescue customer service?
The adoption of AI is surging in call centres
Reign of the spreadsheet
Why Microsoft Excel won’t die
The business world’s favourite software program enters its 40th year
Autonomous cars
The trouble with Elon Musk’s robotaxi dream
Scaling up self-driving taxis will be hard, and competition will be fierce
Weekend profile
Sir Jim Ratcliffe, chemicals magnate turned sports mogul
The British billionaire is buying up teams from sailing to football to cycling